#STTT has achieved an outstanding # 2025 Journal #ImpactFactor – 81.2!! Publications increased in 2025, and so did the Impact Factor!
STTT received over 89,000 citations in 2025. Ranked #1 in #Biochemistry & #MolecularBiology! Over 26 million downloads this year!
We are grateful for your support & contributions to this achievement.
Visit: https://t.co/1O7wqH3f9n
Science Bulletin, Vol. 71, Issue 7
https://t.co/RDve5c1ekH
Cover: Sono-tribocatalytic therapy provokes PANoptosis in cancer cells
https://t.co/Lb3A8EXShC
Inside Front Cover: The BrainNet imperative: why global brain science needs its own ImageNet
moment https://t.co/nZlSJZ1O50
Our new review out in @CellDiscovery : Manganese: biology, physiology and role in disease. We introduce the "manganese renaissance" paradigm for manganese biology. Full text: https://t.co/brhPjj5ZNR, or https://t.co/NFeLtVOdhM
#Manganese#metal#Biometal#Manganese metabolism
The protein Npas3 regulates the energy metabolism of astrocyte cells and is necessary for neuronal function and cognition, a new @ScienceAdvances study shows. https://t.co/2u7m6YLoaM
EHJ issue 47 - 24 is online:
https://t.co/bN6NiiQdZf
The importance of systems cardiology: understanding the interaction between heart failure, kidney disease, liver disease, and cancer.
@escardio@ESC_Journals#EHJ#cardiotwitter
These stunning single-celled organisms can shape-shift & regenerate. Their trumpet-like shape inspired their name: stentor, after the herald in Greek mythology known for his booming voice. 📸: Confocal microscopy by Igor Siwanowicz, HHMI’s Janelia Research Campus
Good Sunday, everyone. Here is a curated summary of papers in #cancermetabolism and #mitochondrialbiology: https://t.co/JxrE82B7Hk. @Bims_BiomedNews
"The most important point is to accept yourself and stand on your two feet."-Shunryū Suzuki
This phase 2 study evaluated abexinostat in relapsed or refractory follicular #lymphoma and reported durable clinical responses with manageable toxicity, highlighting it as a potential treatment strategy for patients with limited therapeutic options.
#STTT#OpenAccess: https://t.co/9TY56365pb
#Hematology #ClinicalTrials #CancerResearch #TargetedTherapy